You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 253 No. 9, March 1, 1985 TABLE OF CONTENTS
  JAMA
  •  Online Features
  SPECIAL COMMUNICATION
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (8)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Potential Use of the National Death Index for Postmarketing Drug Surveillance

Stanley A. Edlavitch, PhD; Manning Feinleib, MD, DrPH; Charles Anello, ScD

JAMA. 1985;253(9):1292-1295.


Abstract

A particularly difficult problem for both the Food and Drug Administration and the pharmaceutical manufacturer is evaluation of the importance of spontaneous reports of suspected drug-associated fatalities. These reports are rare, and usually no accurate denominator data on drug use exist. This article proposes that the National Death Index be used to calculate mortality rates for selected drugs as part of the postmarketing surveillance efforts of the government and manufacturers. When hypotheses are generated from spontaneous reports and/or the mortality data, additional studies can be conducted on the cohorts that were identified for mortality follow-up.

(JAMA 1985;253:1292-1295)



Author Affiliations

From the Epidemiology Development Branch, Division of Drug and Biologic Product Experience (Dr Edlavitch), and the Division of Biometrics (Dr Anello), National Center for Drugs and Biologics, Food and Drug Administration, Rockville, Md; and the National Center for Health Statistics, Hyattsville, Md (Dr Feinleib).


Footnotes

This article represents the personal opinion of the authors. No official support or endorsement by the Food and Drug Administration is intended or should be inferred.

Reprint requests to Division of Epidemiology, School of Public Health, 611 Beacon St SE, Minneapolis, MN 55455 (Dr Edlavitch).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Wanted Dead or Alive: Implication of Death Classification on Longevity
Levy et al.
Research on Aging 2004;26:317-329.
ABSTRACT  

Comparison of National Death Index and World Wide Web Death Searches
Sesso et al.
Am J Epidemiol 2000;152:107-111.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.